BIOSECURE Act gets update, gives US drugmakers until 2032 to sever ties with Chinese biotechs

Lawmakers on Friday introduced a new draft of the BIOSECURE Act, which sets a 2032 deadline for U.S. drug manufacturers to cut their ties with WuXi AppTec, WuXi Biologics and other Chinese biotech companies.